Challenging hepatitis C-infected liver transplant patients

Area of Science:

• Hepatology
• Transplant Surgery
• Infectious Diseases

Background:

• Chronic hepatitis C virus (HCV) infection is a primary indication for liver transplantation in the USA.
• HCV infection in transplant recipients leads to significant morbidity and mortality.
• Managing these patients presents unique challenges due to potential complications and medication interactions.

Purpose of the Study:

• To review the comprehensive management of liver transplant patients with chronic HCV infection.
• To outline critical considerations from pre-transplant evaluation through long-term post-transplant follow-up.
• To highlight specific HCV-related complications and therapeutic strategies.

Main Methods:

• This review synthesizes current literature and clinical guidelines.
• It focuses on pre-transplant recipient and donor selection criteria.
• It examines post-transplant monitoring, immunosuppression, antiviral therapy, and complication management.

Main Results:

• Pre-transplant optimization includes careful donor/recipient matching and aggressive reduction of HCV viral load.
• Post-transplant, patients face risks of fibrosing cholestatic hepatitis and widespread viremia.
• Balancing immunosuppressive and antiviral drugs is crucial to mitigate side effects and manage recurrence.
• Long-term surveillance is necessary to detect cirrhosis and malignancies.

Conclusions:

• Effective management of HCV in liver transplant recipients demands a multidisciplinary approach.
• Careful pre-transplant planning and vigilant long-term follow-up are essential for patient survival and quality of life.
• Addressing HCV-specific complications and optimizing pharmacotherapy are key to successful outcomes.